期刊文献+

未成熟网织红细胞指数在造血干细胞移植中的应用价值 被引量:5

The clinical value of immature reticulocyte fraction in hematopoietic stem cell transplantation
下载PDF
导出
摘要 目的探讨未成熟网织红细胞指数在造血干细胞移植后造血恢复中的应用价值。方法用Sysmex-2000i型自动血细胞分析仪检测25例患者造血干细胞移植后血液的未成熟网织红细胞指数(IRF)、网织红细胞绝对数(RET)、绝对中性粒细胞计数(ANC)等指标。结果25例患者中移植后IRF恢复的天数为14天,比ANC恢复天数早3天,比RET恢复天数早4天。有75%的患者IRF是最早的造血恢复指标。IRF恢复天数分别与ANC、RET恢复天数比较P值均小于0.01,有显著性差异,而ANC和RET恢复天数间比较P值大于0.05,无统计学意义。PBSCT组比BMT组移植后IRF,ANC和RET均提前恢复。结论IRF是造血干细胞移植后骨髓造血功能开始恢复的较敏感指标,可用于病情观察及指导临床治疗。 Objective:To assess the clinical value of immature reticulocyte fraction(IRF) in haematopoietic reconstitution after haematopoietic stem cell transplantation. Methods.Twtnty five patients were analyzed. IRF, absolute reticulocyte count (BET) and absolute neutrophil count (ANC) were measured using Sysmex XE -2100i automated hematology analyzer. Results:In all cases recovery of IRF was 14 days, 3 days before recovery of ANC and 4 days before recovery of BET. The rise of IRF was the earliest sign of haemopietic recovery in 75% of patients. Differences between the days of recovery for IRF and BET and ANC were statistically significant at the P 〈 0.01 level, while the difference between the days of recovery for ANC and BET was not significant. Recovery of IRF, ANC and BET was faster in PBSCT group than in BMT group. Conclusion:The IRF is an early indicator of haemopietic recovery after haematopoietic stem ceil transplantation.
出处 《现代肿瘤医学》 CAS 2006年第5期601-603,共3页 Journal of Modern Oncology
关键词 造血干细胞移植 网织红细胞指数 造血恢复 造血功能 haematopoietic stem cell transplantation ratio of reticulocyte haemopietic recovery
  • 相关文献

参考文献6

二级参考文献17

  • 1Anderlini P, Rizzo J D, Nugent M L, et al. Peripheral blood stem cell donation: an analysis from the international bone marrow transplant registry (IBMTR) and european group for blood and marrow transplant (EB-MT) databases. Bone Marrow Transplantation, 2001,27: 689-- 692.
  • 2Brasel K, McKenna H J, Charrier K, et al. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.Blood,1997,90:3781-3788.
  • 3Anderlini P, Przepiorka D, Korbling M, et al. Blood stem cell procurement: donor safety issues. Bone Marrow Transplantation, 1998, 21(Suppl) :3S35--39.
  • 4Anderlini P, Korbling M. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem-Cells, 1997, 15: 9--17.
  • 5Anderlini P, Korbling M, Chan K W,et al. Long-term follow-up and safety of normal peripheral blood progenitor cell donors treated with filgrastim: the MD anderson cancer center experience [abstract]. Blood, 2001, 98:183--187.
  • 6Theilgaard M K, Raaschou J K, Andersen H, et al.Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of longterm reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Bone-MarrowTransnlant, 1999, 23: 243--249.
  • 7Hoef M V. HLA-identical sibling peripheral blood progenitor cell transplants (PBPCT). Bone Marrow Transplant, 1999. 24: 707--714.
  • 8Ottiger H D. Scheulen B. Beelen D W, et al. Immune reconstitution after allogeneic peripheral blood progenitor cell transplantation [abstract]. Bone marrow transplantation, 1996, 17 (Supp12):135--139.
  • 9Clark L, Clark O, Djulbegovic B, et al. Allogeneic peripheral blood stem cells vs bone marrow transplantation for the therapy of hematological malignancies: a meta-analysis of randomized controlled trials [abstract].Blood, 2001, 98:414--417.
  • 10Bensinger W I, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced malignancies:a retrospective comparison with marrow transplantation. Blood, 1996, 88:2794-- 2800.

共引文献64

同被引文献47

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部